<DOC>
	<DOCNO>NCT00869882</DOCNO>
	<brief_summary>This trial , conduct adult patient degenerative spondylolisthesis need surgical treatment one level , aim compare two approach spinal fusion .</brief_summary>
	<brief_title>SPONGIT : Comparison Two Surgical Approaches Treatment Degenerative Spondylolysthesis</brief_title>
	<detailed_description>Degenerative spondylolisthesis define slip one vertebra onto due degenerative lesion ; L4-L5 intervertebral space mainly involve . Mean age symptomatic disease 60 . Surgery indicate presence radiculalgia and/or neurological claudication and/or invalidate lombalgia , worsen neurological deficit , presence sphincterian incontinence . Surgical treatment degenerative spondylolisthesis usually consist neural decompression follow posterolateral fusion instrumentation . In literature , fusion rate estimate 80 % GPLI seem increase interbody fusion , especially transforaminal lumbar interbody fusion advantage unilateral disc interspace route , fusion rate 90 % . It seem hypolordosis instrument segment cause increased loading posterior column adjacent segment . These biomechanical effect may explain degenerative change junction level observe long-term consequence lumbar fusion . In addition fusion , segmental lordosis gain seem important long-term prognostic factor . Segmental lordosis recovery ( upper 3Â° order take account measurement variability ) , never assess TLIF procedure compare posterolateral fusion control randomized clinical trial . The main objective study comparison efficacy circumferential fusion ( TLIF plus GPLI ) GPLI alone surgical treatment degenerative spondylolisthesis term `` Success '' rate , define fusion least 3-degree increase segmental lordosis angle , 24 month surgery . In trial , include patient randomly assign undergo either posterolateral fusion instrumentation ( GPLI ) circumferential fusion transforaminal lumbar interbody fusion ( TLIF ) combine GPLI . In arm , bone autograft perform use loose fragment obtain neurological decompression . Six visit plan study : pre-inclusion visit within 3 month surgery , inclusion/randomisation day surgery , 3 follow-up visit ( 2 , 6 , 12 month surgery ) end study visit 24 month surgery ( time withdrawal relevant ) . Hospital stay ( one week , average ) plan surgery .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<criteria>Adults age less 75 , Having inform clinical trial objective risk , Covered health insurance system , Suffering degenerative spondylolisthesis ( whatever grade intervertebral disc height ) need onelevel surgical fusion due either invalidate lombalgia/radiculalgia despite 6month optimal medical treatment and/or motor neurological symptom . Previous lumbar fusion , Previous spine traumatism , Presence least one major contraindication surgery and/or general anaesthesia ( ie , non control coagulopathy , active infection , serious underlie disease , autoimmune affection ) . Presence least one contraindication either TLIF GPLI , Severe radiological osteoporosis . Active cancer time inclusion study . Unlikely comply requirement study and/or complete study psychological , social , familial geographical reason . Under administrative legal supervision .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Spondylolisthesis</keyword>
	<keyword>degeneration</keyword>
	<keyword>spinal fusion</keyword>
</DOC>